ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
C437-H682-N122-O134-S13 (α-subunit); C668-H1090-N196-O203-S13(β-subunit)
Recombinant extrapituitary gonadotropin with LH action
Recombinant human chorionic gonadotropin (protein moiety reduced), glycoform α. Complex with α-subunit (human α-subunit protein moiety reduced) and β-subunit (human β-subunit protein moiety reduced)
- Choriogonadotropinum alfa (Latin)
- Choriogonadotropin alfa (German)
- Choriogonadotropine alfa (French)
- Coriogonadotropina alfa (Spanish)
- Choriogonadotropin Alfa (OS: USAN, BAN)
- Choriogonadotropin Alfa (Genetical Recombination) (OS: JAN)
- recombinant human chorionic gonadotropin, glycoform α (IS)
- rhCG (IS)
- UNII-6413W06WR3 (IS)
IBSA Institut Biochimique, Bosnia & Herzegowina
EMD Serono, Canada; EMD Serono, United States; Healthcare Logistics, New Zealand; Merck, Chile; Merck, Hong Kong; Merck, Indonesia; Merck, South Korea; Merck, Mexico; Merck, Philippines; Merck Serono, Argentina; Merck Serono, Australia; Merck Serono, China; Merck Serono, Malaysia
Merck, Belgium; Merck, Switzerland; Merck, Finland; Merck, Georgia; Merck, Croatia (Hrvatska); Merck, Hungary; Merck, Netherlands; Merck, Serbia; Merck, Sweden; Merck, Slovakia; Merck, Turkey; Merck, South Africa; Merck KGaA, Vietnam; Merck S.L., Spain; Merck Sereno, Latvia; Merck Serono, Austria; Merck Serono, Czech Republic; Merck Serono, Germany; Merck Serono, Denmark; Merck Serono, France; Merck Serono, United Kingdom; Merck Serono, Ireland; Merck Serono, Israel; Merck Serono, Iceland; Merck Serono, Italy; Merck Serono, Norway; Merck Serono, Poland; Merck Serono, Portugal; Serono, Greece; Serono, Lebanon
|BAN||British Approved Name|
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.